Mitotic arrest of endometrial epithelium after paclitaxel therapy for breast cancer

International Journal of Gynecological Pathology

Volumn 19, Issue 4, 2000, Pages 395-397

  Irving, Julie A ^a   McFarland, David F ^b   Stuart, David S ^b   Gilks, C Blake ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Burnaby Hospital   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dysfunctional uterine bleeding; Endometrium; Mitotic arrest; Paclitaxel

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; CLINICAL FEATURE; CURETTAGE; DRUG EFFECT; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; METRORRHAGIA; MITOSIS INHIBITION; PRIORITY JOURNAL;

EID: 0033730202     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200010000-00018     Document Type: Article

References (10)

1. Paclitaxel pharmacology and other tumor types
2. Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug Taxol: A review
3. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
4. Inactivation of bcl-2 by phosphorylation
5. Bcl-2 is the guardian of microtubule integrity
6. Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in pre-menopausal breast cancer patients
7. The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer
8. Multiple late complications of therapy with cyclophosphamide, including ovarian destruction
9. Cyclic bcl-2 expression in human uterine endometrium during menstrual cycle
10. Bcl-2 expression in normal endometrium during the menstrual cycle